Impact of Graft Size on Postoperative Thrombocytopenia in Living Donor Liver Transplant | Coagulation Disorders | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
1.
McCaughan  GWHerkes  RPowers  B  et al.  Thrombocytopenia post liver transplantation: correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome.  J Hepatol 1992;16 (1-2) 16- 22PubMedGoogle ScholarCrossref
2.
Ben Hamida  CLauzet  JYRezaiguia-Delclaux  S  et al.  Effect of severe thrombocytopenia on patient outcome after liver transplantation.  Intensive Care Med 2003;29 (5) 756- 762PubMedGoogle Scholar
3.
Shergill  AKKhalili  MStraley  S  et al.  Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C–infected patients undergoing liver transplantation.  Am J Transplant 2005;5 (1) 118- 124PubMedGoogle ScholarCrossref
4.
Marcos  AOlzinski  ATHam  JMFisher  RAPosner  MP The interrelationship between portal and arterial blood flow after adult to adult living donor liver transplantation.  Transplantation 2000;70 (12) 1697- 1703PubMedGoogle ScholarCrossref
5.
Shimada  MIjichi  HYonemura  Y  et al.  The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft.  Hepatogastroenterology 2004;51 (57) 625- 629PubMedGoogle Scholar
6.
Adinolfi  LEGiordano  MGAndreana  A  et al.  Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis.  Br J Haematol 2001;113 (3) 590- 595PubMedGoogle ScholarCrossref
7.
Bashour  FNTeran  JCMullen  KD Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease.  Am J Gastroenterol 2000;95 (10) 2936- 2939PubMedGoogle ScholarCrossref
8.
Sezai  SKamisaka  KIkegami  F  et al.  Regulation of hepatic thrombopoietin production by portal hemodynamics in liver cirrhosis.  Am J Gastroenterol 1998;93 (1) 80- 82PubMedGoogle ScholarCrossref
9.
Rios  RSangro  BHerrero  IQuiroga  JPrieto  J The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.  Am J Gastroenterol 2005;100 (6) 1311- 1316PubMedGoogle ScholarCrossref
10.
Tsukahara  ASato  YYamamoto  S  et al.  Thrombopoietin levels and peripheral platelet counts following living related donor liver transplantation.  Hepatogastroenterology 2003;50 (49) 227- 230PubMedGoogle Scholar
11.
Porte  RJBlauw  EKnot  EA  et al.  Role of the donor liver in the origin of platelet disorders and hyperfibrinolysis in liver transplantation.  J Hepatol 1994;21 (4) 592- 600PubMedGoogle ScholarCrossref
12.
Nagamine  TOhtuka  TTakehara  KArai  TTakagi  HMori  M Thrombocytopenia associated with hepatitis C viral infection.  J Hepatol 1996;24 (2) 135- 140PubMedGoogle ScholarCrossref
13.
Pozzato  CMarzano  LBotta  AAnania  RMUslenghi  CM Splenomegaly and hypersplenism in cirrhotic patients before and after orthotopic liver transplantation [in Italian].  Radiol Med (Torino) 1998;95 (4) 349- 352PubMedGoogle Scholar
14.
Ito  TKiuchi  TYamamoto  H  et al.  Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications.  Transplantation 2003;75 (8) 1313- 1317PubMedGoogle ScholarCrossref
15.
Marubashi  SDono  KNagano  H  et al.  Living-donor liver transplantation with renoportal anastomosis for patients with large spontaneous splenorenal shunts.  Transplantation 2005;80 (12) 1671- 1675PubMedGoogle ScholarCrossref
16.
Schmid  MKreil  AJessner  W  et al.  Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens.  Gut 2005;54 (7) 1014- 1020PubMedGoogle ScholarCrossref
17.
Cescon  MSugawara  YTakayama  T  et al.  Role of splenectomy in living-donor liver transplantation for adults.  Hepatogastroenterology 2002;49 (45) 721- 723PubMedGoogle Scholar
18.
Kishi  YSugawara  YAkamatsu  N  et al.  Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation.  Clin Transplant 2005;19 (6) 769- 772PubMedGoogle ScholarCrossref
19.
Waghorn  DJ Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed.  J Clin Pathol 2001;54 (3) 214- 218PubMedGoogle ScholarCrossref
20.
Neumann  UPLangrehr  JMKaisers  ULang  MSchmitz  VNeuhaus  P Simultaneous splenectomy increases risk for opportunistic pneumonia in patients after liver transplantation.  Transpl Int 2002;15 (5) 226- 232PubMedGoogle Scholar
21.
Troisi  RCammu  GMiliterno  G  et al.  Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation?  Ann Surg 2003;237 (3) 429- 436PubMedGoogle Scholar
22.
Matsukura  AKita  YHarihara  Y  et al.  Is splenic artery ligation effective for thrombocytopenia early after liver transplantation?  Transplant Proc 1999;31 (7) 2906- 2907PubMedGoogle ScholarCrossref
23.
Sangro  BBilbao  IHerrero  I  et al.  Partial splenic embolization for the treatment of hypersplenism in cirrhosis.  Hepatology 1993;18 (2) 309- 314PubMedGoogle ScholarCrossref
Original Article
November 1, 2007

Impact of Graft Size on Postoperative Thrombocytopenia in Living Donor Liver Transplant

Author Affiliations

Author Affiliations: Department of Surgery and Clinical Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.

Arch Surg. 2007;142(11):1054-1058. doi:10.1001/archsurg.142.11.1054
Abstract

Hypothesis  Perioperative variables, including portal venous pressure (PVP) and graft size, can predict thrombocytopenia after living donor liver transplant (LDLT).

Design  Retrospective analysis.

Setting  University hospital.

Patients  Forty-five adult patients with liver cirrhosis who underwent LDLT without splenectomy (n = 38) or with simultaneous splenectomy (n = 7).

Main Outcome Measures  Preoperative and postoperative platelet counts and perioperative variables of recipient age, preoperative Model for End-Stage Liver Disease score, donor age, graft volume to standard liver volume ratio, PVP, cold and warm ischemia times, blood loss, and surgical complications.

Results  In the 38 recipients who did not undergo splenectomy, there was a strong correlation between PVP at the completion of the transplant and the platelet count (at 14 and 28 days and at 3 months). A high PVP (≥ 25 mm Hg) correlated with posttransplant thrombocytopenia, as did a small graft. Patients undergoing a simultaneous splenectomy had sufficient platelet levels at each measurement, irrespective of the graft volume.

Conclusions  Portal venous pressure and graft size were associated with posttransplant thrombocytopenia. Splenectomy is an option in cases with a high PVP or a small graft, especially for patients receiving postoperative interferon therapy for hepatitis C virus.

×